Toyota|$17.71 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.33 (¥4,365)+2.92%▲ (in JPY terms)
SoftBank|$22.15 (¥3,537)+4.55%▲ (in JPY terms)
MUFG|$20.02 (¥3,197)-1.66%▼ (in JPY terms)
Keyence|$91.99 (¥14,690)-0.20%▼ (in JPY terms)
Nintendo|$58.28 (¥9,306)+3.38%▲ (in JPY terms)
NTT|$1.06 (¥169)-0.76%▼ (in JPY terms)
Takeda|$43.52 (¥6,950)+1.18%▲ (in JPY terms)
Tokyo Electron|$55.98 (¥8,940)+2.77%▲ (in JPY terms)
Recruit|$111.56 (¥17,815)+1.31%▲ (in JPY terms)
ITOCHU|$14.35 (¥2,291)-1.16%▼ (in JPY terms)
Honda|$11.21 (¥1,790)-1.08%▼ (in JPY terms)
Shin-Etsu|$34.62 (¥5,529)-0.11%▼ (in JPY terms)
Tokio Marine|$3.54 (¥566)-2.63%▼ (in JPY terms)
Fast Retailing|$522.07 (¥83,370)+0.40%▲ (in JPY terms)
Toyota|$17.71 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$27.33 (¥4,365)+2.92%▲ (in JPY terms)
SoftBank|$22.15 (¥3,537)+4.55%▲ (in JPY terms)
MUFG|$20.02 (¥3,197)-1.66%▼ (in JPY terms)
Keyence|$91.99 (¥14,690)-0.20%▼ (in JPY terms)
Nintendo|$58.28 (¥9,306)+3.38%▲ (in JPY terms)
NTT|$1.06 (¥169)-0.76%▼ (in JPY terms)
Takeda|$43.52 (¥6,950)+1.18%▲ (in JPY terms)
Tokyo Electron|$55.98 (¥8,940)+2.77%▲ (in JPY terms)
Recruit|$111.56 (¥17,815)+1.31%▲ (in JPY terms)
ITOCHU|$14.35 (¥2,291)-1.16%▼ (in JPY terms)
Honda|$11.21 (¥1,790)-1.08%▼ (in JPY terms)
Shin-Etsu|$34.62 (¥5,529)-0.11%▼ (in JPY terms)
Tokio Marine|$3.54 (¥566)-2.63%▼ (in JPY terms)
Fast Retailing|$522.07 (¥83,370)+0.40%▲ (in JPY terms)

2026-03-02 Astellas Pharma Inc. “Results from the Phase III EV-304 trial of the antibody-drug conjugate PADCEV™ (enfortumab vedotin) in cisplatin-eligible muscle-invasive bladder cancer were presented at the 2026 American Society of Clinical Oncology (ASCO GU) Annual Meeting.”

2026-03-02 Astellas Pharma Inc. “Results from the Phase III EV-304 trial of the antibody-drug conjugate … 続きを読む